Associations
newsletter
subscribe
advertise
contact
Technology
pulseTV
Buyer's Guide
Comparison Charts
Blogs
Events
Webinars
Magazine
Cardiac Diagnostics
ECG
ECG Management Systems
Holter Monitoring Systems
Stress Test Systems
Cardiac Imaging
Advanced Visualization
Angiography Systems
Cardiovascular Ultrasound
Contrast Media
CT Systems
Hybrid OR
MRI Systems
Nuclear Imaging
Cath Lab
Angiography Systems
Balloon Catheters
Hemostasis Management
Intravascular Imaging Systems
Interventional Radiology
Hybrid OR
Radial Access
Stents
Ventricular Assist Devices (VAD)
EP Lab
Ablation Systems
Cardiac Resynchronization Therapy Devices (CRT)
Implantable Cardioverter Defibrillators (ICD)
Leads, implantable devices
Pacemakers
Information Technology
Advanced Visualization
Cardiac PACS
Telecardiology
Structural Heart
Heart Valve Repair
Hybrid OR
Left Atrial Appendage (LAA) Occluders
Structural Heart Occluders/Closure Devices
CorMatrix Cardiovascular Inc.
155-A Moffett Park Drive
Suite 240
Sunnyvale
CA
94089
USA
Phone:
877-651-2628
Fax:
408-734-2629
http://www.cormatrix.com
ecm@cormatrix.com
Product Categories: Taxo=cardiovascular_surgery&Taxo=diagnostic_and_interventional_cardiology_daic
Related Articles
Cardiac Stem Cell/Regeneration therapy
FDA OKs Trial Evaluating CorMatrix to Prevent Postoperative Atrial Fibrillation
Cardiac Regeneration After MI: Role of the Extracellular Matrix
FDA Clears Trial to Reduce Incidence of New Onset Postoperative Atrial Fibrillation
ECM Device Receives CE Mark for Cardiac Tissue Repair
Tissue Regeneration Used to Rebuild Patients’ Heart Structures
Structural Heart
Cardiac Regeneration After MI: Role of the Extracellular Matrix
FDA Clears Trial to Reduce Incidence of New Onset Postoperative Atrial Fibrillation
Clinical Trial/Study
FDA Clears Trial to Reduce Incidence of New Onset Postoperative Atrial Fibrillation
Heart Valve Repair
Tissue Regeneration Used to Rebuild Patients’ Heart Structures
Cardiovascular Surgery
Implants of CorMatrix ECM Technology Begin in Europe
